Researchers of this randomized trial (IGNITE) tested whether using continuous glucose monitoring (CGM) versus finger-stick blood glucose monitoring (BGM) to guide diet and medication during a medically supervised ketogenic diet program (delivered via continuous remote care) would differentially improve glycemia in adults with type 2 diabetes.
